Screening for gynecologic cancer.
Screening for cervical cancer with the Pap test has significantly reduced mortality from the disease. Although screening for ovarian and endometrial cancer is desirable, suggested strategies have not demonstrated efficacy. For the present time, educating patients with regard to the symptoms associated with these diseases and prompt evaluation of women who present with these symptoms helps limit unnecessary diagnostic delay.
Zanotti
K M
KM
Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Ohio, USA. zanottk@cesmtp.ccf.org
Kennedy
A W
AW
D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis* / Q000517:prevention & control*; D006801:Humans; D008403:Mass Screening; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D014626:Vaginal Smears